Breast Cancer and Pregnancy: Navigating Diagnosis, Treatment, and Survivorship

This informative and supportive session will explore the complex intersection of breast cancer and pregnancy. Dr. Amanda Manorot and Dr. Erin Cobain will discuss how to navigate a new cancer diagnosis during pregnancy, including the impact of imaging and treatment on maternal and fetal health. The webinar will also address delivery planning with a cancer diagnosis, considerations around breastfeeding after treatment, and the emotional and psychological effects of having to stop—or not being able to start—breastfeeding. Finally, the session will cover future fertility and considerations for pregnancy after cancer treatment. Ideal for patients, caregivers, and healthcare professionals seeking guidance in this nuanced area of care.

This activity offers maximum educational hours of:

1.25 contact hours for NURSES
1.00 clock hours for SOCIAL WORKERS
1.25 educational hours for OTHER Healthcare Professionals (Certificate of Completion)

For requirements see “Continuing Education Solutions Purpose, Objectives, and Disclosures”

Amanda Manorot, MD
Clinical Assistant Professor
Department of Obstetrics and Gynecology
University of Michigan

Dr. Amanda Manorot is a Clinical Assistant Professor at the University of Michigan in the Department of Obstetrics and Gynecology. She has completed her training in Obstetrics and Gynecology followed by subspecialized fellowship training in Cancer Genetics and Breast Health. She provides comprehensive gynecologic care to breast cancer survivors and patients with gene mutations or family history that elevate their risk for breast and ovarian cancers. 

Erin Cobain, MD
Associate Professor of Internal Medicine
Division of Hematology/Oncology
University of Michigan Rogel Cancer Center

Dr. Erin Cobain is an Associate Professor of Internal Medicine in the Division of Hematology/Oncology at the University of Michigan Rogel Cancer Center where she serves as Co-Chair of the Breast Cancer Clinical Research Team. Her research focuses on identifying those at high risk of developing breast cancer and personalizing therapy for those with a breast cancer diagnosis through tumor molecular and genomic profiling. Dr. Cobain is very active within the SWOG breast cancer committee, currently serving as study chair of an NCTN clinical trial exploring use of combination chemo-immunotherapy for patients with high-risk, hormone receptor positive, HER2-negative early-stage breast cancer. She is also very active within ASCO, serving on the TAPUR molecular tumor board, annual meeting Education Committee for Prevention, Risk Reduction and Hereditary Cancers, the Government Relations Committee and is a recent graduate of the ASCO Leadership Development Program.